These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 31012418)

  • 1. Should a Psychiatrist Prescribe a Nanodrug to Help Parents Monitor a Teen's Adherence?
    George CE
    AMA J Ethics; 2019 Apr; 21(4):E317-323. PubMed ID: 31012418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Should Trackable Pill Technologies Be Used to Facilitate Adherence Among Patients Without Insight?
    Rahman T
    AMA J Ethics; 2019 Apr; 21(4):E332-336. PubMed ID: 31012420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of patient support program and adherence to long-acting injectable aripiprazole for patients utilizing injection local care centers.
    Greene M; Burudpakdee C; Seetasith A; Behling M; Krasa H
    Curr Med Res Opin; 2019 Jan; 35(1):97-103. PubMed ID: 30322282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does the Psychiatrist's Use of Subjective Well-Being Measurement in People with Schizophrenia Provide a Better Alignment with the Patient's Well-Being Perception than Clinical Judgement Alone?
    Aunjitsakul W; Teetharatkul T; Vitayanont A; Liabsuetrakul T
    Adm Policy Ment Health; 2021 Sep; 48(5):768-779. PubMed ID: 33728557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment adherence in schizophrenia. A comparison between patient's, relative's and psychiatrist's opinions].
    Giner J; Cañas F; Olivares JM; Rodriguez A; Burón JA; Rodríguez-Morales A; Roca M
    Actas Esp Psiquiatr; 2006; 34(6):386-92. PubMed ID: 17117335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A multicentre, randomized, naturalistic, open-label study between aripiprazole and standard of care in the management of community-treated schizophrenic patients Schizophrenia Trial of Aripiprazole: (STAR) study.
    Kerwin R; Millet B; Herman E; Banki CM; Lublin H; Pans M; Hanssens L; L'Italien G; McQuade RD; Beuzen JN
    Eur Psychiatry; 2007 Oct; 22(7):433-43. PubMed ID: 17555947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-Acting Injectable Antipsychotics in Schizophrenia: Literature Review and Practical Perspective, with a Focus on Aripiprazole Once-Monthly.
    Biagi E; Capuzzi E; Colmegna F; Mascarini A; Brambilla G; Ornaghi A; Santambrogio J; Clerici M
    Adv Ther; 2017 May; 34(5):1036-1048. PubMed ID: 28382557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improving Adherence in Hospitalized Patients Diagnosed With Schizophrenia: An Integrative One-on-One Intervention.
    Dahan S; Behrbalk P; Stolovy T; Greenberger C
    Arch Psychiatr Nurs; 2016 Dec; 30(6):660-665. PubMed ID: 27888956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Attitudes toward antipsychotic medications as a useful feature in exploring medication non-adherence in schizophrenia.
    Samalin L; de Chazeron I; Blanc O; Brunel L; Fond G; Llorca PM
    Schizophr Res; 2016 Dec; 178(1-3):1-5. PubMed ID: 27637362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medication Adherence and Discontinuation of Aripiprazole Once-Monthly 400 mg (AOM 400) Versus Oral Antipsychotics in Patients with Schizophrenia or Bipolar I Disorder: A Real-World Study Using US Claims Data.
    Yan T; Greene M; Chang E; Hartry A; Touya M; Broder MS
    Adv Ther; 2018 Oct; 35(10):1612-1625. PubMed ID: 30206822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validity of the 24-h medication use recall for assessing medication adherence among psychiatric outpatients.
    Adelufosi AO; Ogunwale A
    Asian J Psychiatr; 2013 Feb; 6(1):85. PubMed ID: 23380328
    [No Abstract]   [Full Text] [Related]  

  • 12. The safety, efficacy and tolerability of Abilify Maintena for the treatment of schizophrenia.
    Kahn RS; Giannopoulou A
    Expert Rev Neurother; 2015; 15(9):969-81. PubMed ID: 26289486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychiatrist and patient responses to suspected medication nonadherence in schizophrenia spectrum disorders.
    Hamann J; Lipp ML; Christ-Zapp S; Spellmann I; Kissling W
    Psychiatr Serv; 2014 Jul; 65(7):881-7. PubMed ID: 24686753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and application of an aggregate adherence metric derived from population pharmacokinetics to inform clinical trial enrichment.
    Knights J; Rohatagi S
    J Pharmacokinet Pharmacodyn; 2015 Jun; 42(3):263-73. PubMed ID: 25821065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment Patterns, Health Care Resource Utilization, and Spending in Medicaid Beneficiaries Initiating Second-generation Long-acting Injectable Agents Versus Oral Atypical Antipsychotics.
    Pilon D; Tandon N; Lafeuille MH; Kamstra R; Emond B; Lefebvre P; Joshi K
    Clin Ther; 2017 Oct; 39(10):1972-1985.e2. PubMed ID: 28919292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Therapeutic alliance, a stake in schizophrenia].
    Charpentier A; Goudemand M; Thomas P
    Encephale; 2009 Feb; 35(1):80-9. PubMed ID: 19250998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors associated with medication adherence among patients with schizophrenia in Mekelle, Northern Ethiopia.
    Eticha T; Teklu A; Ali D; Solomon G; Alemayehu A
    PLoS One; 2015; 10(3):e0120560. PubMed ID: 25816353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors associated with antipsychotic medication adherence in community-based patients with schizophrenia in Hong Kong: a cross sectional study.
    Bressington D; Mui J; Gray R
    Int J Ment Health Nurs; 2013 Feb; 22(1):35-46. PubMed ID: 22738372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness of olanzapine in the first-line treatment of schizophrenia in China.
    Zhao J; Jiang K; Li Q; Zhang Y; Cheng Y; Lin Z; Xuan J
    J Med Econ; 2019 May; 22(5):439-446. PubMed ID: 30732487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can a digital medicine system improve adherence to antipsychotic treatment?
    Papola D; Gastaldon C; Ostuzzi G
    Epidemiol Psychiatr Sci; 2018 Jun; 27(3):227-229. PubMed ID: 29528032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.